keyword
https://read.qxmd.com/read/38633677/patient-controlled-therapy-with-intravenous-oxycodone-in-breathlessness-due-to-advanced-cancer-a-case-report
#1
Mahesh Radhakrishnan Menon, Shiv Pratap Singh Rana, Subashini Perumal, Khawla Fuad
Dyspnoea is a debilitating symptom in medicine, especially in palliative care. Opioids are the pharmacological agents of choice in the treatment of dyspnoea in palliative medicine. Morphine is the best-studied opioid, and recent literature on oxycodone is encouraging. In refractory cases, opioid infusion and palliative sedation may have to be used. We present a case that used oxycodone in a patient-controlled device specifically for dyspnoea and its effects in relieving dyspnoea in a fast and timely manner...
2024: Indian Journal of Palliative Care
https://read.qxmd.com/read/38553921/a-retrospective-study-of-breathlessness-supportive-therapy-on-chronic-refractory-breathlessness-in-a-palliative-care-unit
#2
JOURNAL ARTICLE
K T Tay, N N Nik Isahak, N Kasinathan, C L Yeat, N D Saad
INTRODUCTION: Chronic refractory breathlessness is a debilitating symptom which negatively affects quality of life with profound impact on physical and psychosocial functioning of patients and/or carers. Multidisciplinary based interventions which focus on non-pharmacological approach have shown to be effective. We developed a breathlessness intervention service called breathlessness supportive therapy (BST) in a palliative care unit with limited resources. The aim is to evaluate the feasibility of developing a BST service and to study the characteristics and outcome of patients with chronic refractory breathlessness...
March 2024: Medical Journal of Malaysia
https://read.qxmd.com/read/38541060/opioids-in-treatment-of-refractory-dyspnea-in-chronic-obstructive-pulmonary-disease-yes-no-or-maybe
#3
REVIEW
Ruxandra-Mioara Rajnoveanu, Antonia Harangus, Doina Adina Todea, Milena Adina Man, Corina Eugenia Budin, Armand-Gabriel Rajnoveanu
Chronic Obstructive Pulmonary Disease (COPD) is a complex condition with significant impact on prognosis, especially in advanced stages where symptom burden becomes critical. Breathlessness affects patients' quality of life, and despite various therapeutic strategies, the role of opioids in palliative care for COPD remains under investigation. The acceptance of a therapeutic trial of different types of opioids is increasing not only in end-of-life situations but also for stable COPD patients experiencing intolerable refractory breathlessness despite optimal conventional therapy...
March 19, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38269313/untangling-asthma-inducible-laryngeal-obstruction-and-dysfunctional-breathing-in-a-competitive-sportsperson
#4
Alice L Crawford, Niranjan Setty, Brooke Kyle, Kate Baumwol, John D Blakey
A young woman with historically mild asthma experienced worsening breathlessness and cough with competitive ice skating. Despite optimizing and escalating treatment for her eosinophilic asthma, and addressing known exacerbating factors, her symptoms remained uncontrolled and refractory to bronchodilators and oral corticosteroids. Objective testing suggested her presentation was out of keeping with asthma alone, and she was suspected to have comorbid dysfunctional breathing and/or inducible laryngeal obstruction...
January 2024: Respirology Case Reports
https://read.qxmd.com/read/38176572/frequency-and-characteristics-of-refractory-dyspnea-in-idiopathic-fibrosing-interstitial-pneumonia
#5
JOURNAL ARTICLE
Nathalie Bautin, Juliette Ferlin, Gaelle Terce, Camille Ternynck, Victor Valentin, Lidwine Wemeau, Cecile Chenivesse
Patients with idiopathic fibrosing interstitial pneumonias (f-IIPs) mainly suffer from dyspnea. Refractory dyspnea, defined as persistent dyspnea despite optimal treatment, could be the signal to prescribe dyspnea relievers. We aimed to examine the prevalence and characteristics of refractory dyspnea in consecutive patients with f-IIPs. Refractory dyspnea was defined by an mMRC≥3 and also by a VAS dyspnea score≥2 at rest. The sensory and affective characteristics of refractory dyspnea (mMRC≥3) and associated quality of life (QoL) anxiety and depression were compared with non-refractory dyspnea (mMRC1-2) using the Multidimensional Dyspnea Profile (MDP), King's Brief Interstitial Lung Disease (KBILD) and Hospital Anxiety and Depression scale (HADs)...
January 3, 2024: Respiratory Medicine
https://read.qxmd.com/read/38117107/-early-palliative-care-for-the-management-of-breathlessness-in-pulmonary-diseases
#6
JOURNAL ARTICLE
Ivan Guerreiro, Sophie Pautex, Anne Bergeron, Filipa Baptista Peixoto Befecadu, Lisa Hentsch
Dyspnoea in chronic respiratory disease is a very frequent symptom with a significant impact on quality of life (QoL). The aim of palliative care is to improve and maintain the QoL of patients with life-threatening diseases and its early implementation is now recommended in many evolving pulmonary diseases. The effectiveness of symptomatic treatments to relieve refractory breathlessness (morphine, oxygen supply, hypnosis, pulmonary rehabilitation) is often limited. These measures are more effective if offered early in the holistic management of the patient...
December 20, 2023: Revue Médicale Suisse
https://read.qxmd.com/read/38024114/a-case-of-constrictive-pericarditis-with-a-milk-of-calcium-pericardial-effusion-undergoing-surgical-treatment
#7
Shojiro Hirano, Masaya Shinohara, Rine Nakanishi, Takahide Sano, Shintaro Yao, Keisuke Hosono, Takeshiro Fujii, Takanori Ikeda
UNLABELLED: Milk of calcium (MOC) pericardial effusion (PE) is extremely rare and has rarely been reported. A 78-year-old man was referred to our institution because of breathlessness and bilateral leg edema. Echocardiography revealed mild PE. In addition, abrupt posterior motion of the ventricular septum in early diastole was observed. A non-contrast chest computed tomography revealed a hyperdense PE, with Hounsfield units of 130, suggestive of MOC PE. Right heart catheterization (RHC) revealed that the right ventricular pressure had a dip and plateau pattern...
November 2023: Journal of Cardiology Cases
https://read.qxmd.com/read/37724226/covid-19-mortality-in-the-delta-wave-in-india-a-hospital-based-study-from-ramanagara-district-karnataka
#8
JOURNAL ARTICLE
Amita Mukhopadhyay, Geetha Kb, Ipsita Debata, Charithra Bv, Manju Prakash, Tejas J
INTRODUCTION: Coronavirus 19 (COVID-19) disease spread rapidly over the world since its inception in December 2019 in Wuhan, China. India too was crippled by the burden of high caseloads and deaths. The first death caused by COVID-19 in Karnataka was reported on March 13, 2020. There is a plethora of information on the descriptive statistics, epidemiology, and management of COVID-19 cases. However, there has not been an in-depth and extensive exploration of COVID-19 mortality data in terms of published research from India...
August 2023: Curēus
https://read.qxmd.com/read/37710987/effectiveness-and-safety-of-opioids-on-breathlessness-and-exercise-endurance-in-patients-with-chronic-obstructive-pulmonary-disease-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#9
REVIEW
Meilu Liu, Wei Xiao, Longyi Du, Yan Yu, Xugui Chen, Bing Mao, Juanjuan Fu
BACKGROUND: Opioids are recommended to treat advanced refractory dyspnoea despite optimal therapy by the American Thoracic Society clinical practice guidelines, while newly published randomised controlled trials of opioids in chronic obstructive pulmonary disease yield conflicting results. AIM: This study aimed to evaluate the effectiveness and safety of opioids for patients with chronic obstructive pulmonary disease. DESIGN: Systematic review and meta-analysis (PROSPERO CRD42021272556)...
October 2023: Palliative Medicine
https://read.qxmd.com/read/37523697/in-adults-with-hf-opioids-do-not-reduce-refractory-breathlessness-low-certainty-evidence
#10
JOURNAL ARTICLE
Muhammad Shahzeb Khan, Harriette G C Van Spall
Gaertner J, Fusi-Schmidhauser T, Stock S, et al. Effect of opioids for breathlessness in heart failure: a systematic review and meta-analysis. Heart. 2023;109:1064-1071.36878671.
August 1, 2023: Annals of Internal Medicine
https://read.qxmd.com/read/37147107/atypical-case-of-infective-endocarditis
#11
JOURNAL ARTICLE
Abraham M Ittyachen, Ancy Peter, Anjely Sukumaran, Joy Vinu
A man in his late 40s presented to the emergency department with generalised tiredness and breathlessness. He was a known case of chronic obstructive pulmonary disease and also had a recent history of COVID-19. At arrival, he was in respiratory failure. Blood culture grew Streptococcus parasanguinis , a commensal gram-positive bacterium and a primary coloniser of the human oral cavity. Echocardiogram revealed the presence of a flail mitral valve with vegetation suggestive of infective endocarditis. Although biomarkers of inflammation/infection had improved, he continued to be in cardiac failure, and hence he underwent mitral valve replacement with a mechanical valve...
May 5, 2023: BMJ Case Reports
https://read.qxmd.com/read/36600876/a-case-report-of-cyanosis-with-refractory-hypoxemia-is-it-methemoglobinemia
#12
Sangita D Kamath, Shashank Sunny, Ajatshatru Upadhyay
Dapsone is used in the treatment of a variety of dermatological conditions and prophylaxis of opportunistic infections. However, if consumed at a dose of more than 200 mg/day, it can cause methemoglobinemia, a condition characterized by elevated methemoglobin levels in the blood; methemoglobin is an abnormal form of hemoglobin, containing iron in the ferric state (Fe3 + ) rather than the reduced ferrous form (Fe2 + ) found in hemoglobin. A small amount of it is produced in the body due to oxidant damage to the red blood cells...
November 2022: Curēus
https://read.qxmd.com/read/36451139/-when-i-am-breathless-now-i-don-t-have-the-fear-that-s-linked-to-it-a-case-series-on-the-potential-of-emdr-to-break-the-dyspnea-anxiety-cycle-in-copd
#13
RANDOMIZED CONTROLLED TRIAL
Kris Mooren, Kirsten Smit, Yvonne Engels, Daisy Janssen, Judith Godschalx
BACKGROUND: Expectations can enhance the intensity and the neural processing of breathlessness. Previous breathlessness episodes may influence the perception of subsequent episodes because of psycho-traumatic consequences. In post-traumatic stress disorder, eye movement desensitization and reprocessing (EMDR) is the therapy of choice. AIMS AND OBJECTIVES: We explored the hypothesis that EMDR in patients with chronic obstructive pulmonary disease (COPD) and previous severe breathlessness episodes, improves breathlessness mastery by decreasing the anxiety component...
December 1, 2022: BMC Pulmonary Medicine
https://read.qxmd.com/read/36447510/effectiveness-of-morphine-in-managing-refractory-dyspnoea-in-patients-with-coronavirus-disease-covid-19
#14
Prashant Sirohiya, Khushboo Pandey, Hari Krishna Raju Sagiraju, Sushma Bhatnagar
Opiates are generally used to relieve dyspnoea in advanced diseases such as cancer and lung diseases. However, little is known regarding the safety and efficacy of morphine for refractory dyspnoea in coronavirus disease 2019 (COVID-19) patients. We retrospectively reviewed records of 18 COVID-19-positive patients who were administered morphine for refractory dyspnoea during hospitalisation between May 2021 and June 2021. Details of morphine usage, vital signs, an 11-point dyspnoea numeric rating scale (DNRS) and adverse events at baseline, 24 h and 72 h after the start of treatment were abstracted from records...
2022: Indian Journal of Palliative Care
https://read.qxmd.com/read/36004678/filling-the-gap-a-feasibility-study-of-a-copd-specific-breathlessness-service
#15
JOURNAL ARTICLE
Kris Mooren, Danielle Wester, Huib Kerstjens, Erik Bergkamp, Anna Spathis, Yvonne Engels
Refractory breathlessness is a devastating symptom in chronic obstructive pulmonary disease (COPD). Symptom-focused breathlessness services, involving palliative care teams, offer individualized support but are not yet widely available for people with nonmalignant disease among which COPD. Our primary aim was to demonstrate the feasibility of setting up a breathlessness service specifically for COPD patients within a respiratory outpatient clinic. Our secondary aims were to assess how many sessions patients need to complete the intervention; to obtain an indication of effect size (on the Chronic Respiratory Questionnaire (CRQ), subset mastery domain); and to evaluate patient and professional satisfaction...
2022: COPD
https://read.qxmd.com/read/35985750/transconduit-approach-for-pulmonary-vein-stenting-in-an-extracardiac-fontan-and-plastic-bronchitis-case
#16
JOURNAL ARTICLE
Kumiyo Matsuo, Masaki Hirose, Hisaaki Aoki, Futoshi Kayatani
Plastic bronchitis (PB) is a rare but severe complication in patients following the Fontan operation, the final palliative procedure for single ventricle heart disease. PB is characterised by the formation of rubbery casts of the tracheobronchial tree that may cause cough, wheezing, dyspnoea and hypoxia. Progressive airway obstruction may lead to asphyxia and death, and the overall mortality rate is 15.2%. Most patients receive a combination therapy from three different treatment strategies, that is, therapy for relief of airway obstruction, anti-inflammatory treatment and treatment to improve haemodynamics of the Fontan physiology...
August 19, 2022: BMJ Case Reports
https://read.qxmd.com/read/35722499/how-to-choose-the-correct-drug-in-severe-pediatric-asthma
#17
REVIEW
Andrew Bush
When a child with severe asthma (asthma defined clinically for the purposes of this review as wheeze, breathlessness, and chest tightness sometimes with cough) does not respond to treatment, it is important to be sure that an alternative or additional diagnosis is not being missed. In school age children, the next step is a detailed protocolized assessment to determine the nature of the problem, whether within the airway or related to co-morbidities or social/environmental factors, in order to personalize the treatment...
2022: Frontiers in Pediatrics
https://read.qxmd.com/read/35488689/a-63-year-old-man-with-hypoxemia-and-shock-after-initial-recovery-from-covid-19-pneumonia
#18
JOURNAL ARTICLE
Sahajal Dhooria, Amanjit Bal, Mandeep Garg, Sanjay Jain, Mini P Singh, Inderpaul Singh Sehgal, Ritesh Agarwal, Ashutosh Nath Aggarwal
A 63-year-old man presented with fever and breathlessness during the coronavirus disease 2019 (COVID-19) pandemic. He was diagnosed to have severe COVID-19 pneumonia. He was treated with oxygen, noninvasive ventilation, and glucocorticoids. He improved over 5 weeks and was shifted out of the intensive care unit. Subsequently, he experienced worsening during hospitalization with refractory hypoxemia and shock and finally succumbed to his illness. An autopsy was performed. Herein, we have presented a clinical discussion on the possible causes of the patient's fatal outcome followed by the autopsy findings...
May 2022: Lung India: Official Organ of Indian Chest Society
https://read.qxmd.com/read/35441562/systematic-review-of-common-refractory-symptoms-in-the-end-of-life-situation-and-its-relation-with-euthanasia
#19
JOURNAL ARTICLE
Alba Lucena, Oriol Yuguero
AIM: To analyse the available evidence regarding refractory symptoms to treatment in patients receiving palliative/terminal healthcare. DESIGN: A systematic review of various databases between September and December 2020; Pubmed; Cochrane; Scopus and ScienceDirect. Study eligibility criteria: Studies published between 1st January 2015 and 31st of March 2020, in Spanish, English or Catalan conducted in elderly people or terminal patients. The study included systematic reviews, clinical trials and interventions...
April 20, 2022: Omega
https://read.qxmd.com/read/34761726/barriers-to-prescribing-opioids-in-the-management-of-chronic-breathlessness-in-copd-a-review
#20
REVIEW
Emma Keogh, E Mark Williams
In people with COPD breathlessness is a common symptom and if mistreated can result in poor physical health and reduced quality of life. While it is important to manage the breathlessness using non-pharmacological management, persistent breathlessness may be treated with opioids. However, some physicians are reluctant to prescribe opioids to manage breathlessness in COPD. The aim of this review is to report the views, attitudes and barriers (if any) of healthcare professionals towards using opioids to manage chronic breathlessness in COPD...
December 2021: COPD
keyword
keyword
168326
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.